Godsey & Gibb’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Godsey & Gibb's AMGN Position: Q3 2026 in Review
Godsey & Gibb reduced its Amgen (AMGN) stake by 1.8% in Q3 2026, selling an estimated $526K and leaving 70,261 shares worth $29.6M. The position accounts for 2.44% of the portfolio, ranked #12.
Godsey & Gibb first reported a position in AMGN in Q1 2019 and has held it in 27 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Godsey & Gibb held 70,261 shares of Amgen worth $29.6M as of Q3 2026.
- Godsey & Gibb sold 1,319 Amgen shares in Q3 2026, an estimated $526K.
- Amgen made up 2.44% of Godsey & Gibb's portfolio in Q3 2026, its #12 holding.
- Godsey & Gibb first reported a position in Amgen in Q1 2019 and has held it in 27 quarters since.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Godsey & Gibb's 13F filing for Q3 2026, filed 14 Oct 2026.